Tiling genomes of pathogenic viruses identifies potent antiviral shRNAs and reveals a role for secondary structure in shRNA efficacy

Specific small hairpin RNAs can interfere with the replication of pathogenic viruses and are currently being tested as antiviral therapies in clinical trials: This paper identifies potent shRNAs for HIV, hepatitis C virus (HCV), and influenza.